Zonisamide T0267
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Zonisamide, a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures. It may inhibit a carbonic anhydrase although this is not one of the main mechanisms of action. Zonisamide may act by blocking r
CAS nr:
68291-97-4
Purity:
98%
Molecular Weight:
212,23
SMILES:
NS(=O)(=O)Cc1noc2ccccc12
Formula:
C8H8N2O3S
Pathway:
Metabolism,Metabolism,Membrane transporter/Ion channel,Membrane transporter/Ion channel
Target:
Carbonic Anhydrase,Calcium Channel,Calcium Channel,Sodium Channel
